Some of these biomarkers, like NSE, have very slow elimination from plasma, thus causing diagnostic dilemmas in distinguishing between primary and secondary brain injury, while S100B has a very short half-life and may not be significant in the early stages of injury [ 51 ] .
← all excerpts
Advances in biomarkers for predicting outcomes in pediatric neurosurgical hemorrhagic conditions: a narrative review to enhance quality of care.
1
—
—